Market Overview

Aimmune Therapeutics (NASDAQ: AIMT)

29.23 -0.96 (-3.20%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2019
After-Hours
EPS:
REV:
-0.92



Q4 2018
Pre-Market
EPS:
REV:
-0.82



Q3 2018
Pre-Market
EPS:
REV:
-0.63



Q2 2018
After-Hours
EPS:
REV:
-0.65



Q1 2018
After-Hours
EPS:
REV:
-0.52
-0.71
-0.92
29.58%
Q4 2017
Pre-Market
EPS:
REV:
-0.55

-0.82

Q3 2017
Pre-Market
EPS:
REV:
-0.53
-0.72
-0.63
-12.5%
Q2 2017
After-Hours
EPS:
REV:
-0.43
-0.64
-0.65
1.56%
Q1 2017
Pre-Market
EPS:
REV:
-0.37
-0.56
-0.52
-7.14%
Q4 2016
Pre-Market
EPS:
REV:
-0.39
-0.47
-0.55
17.02%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!